Factor VIII deficiency, also known as hemophilia A, is an inherited bleeding disorder that affects how blood clots in the body. When a person has this condition, their blood lacks enough of a special protein called factor VIII, which is essential for stopping bleeding after an injury. This shortage means that even small cuts or bumps can lead to prolonged bleeding, and sometimes bleeding can happen without any apparent cause at all.

Understanding Factor VIII Deficiency

Factor VIII deficiency, commonly called hemophilia A or classical hemophilia, represents the most widespread type of hemophilia. This condition occurs when the body does not produce enough of a clotting protein known as factor VIII. Blood clotting is normally a complex process that involves many different proteins working together to form a plug at the site of an injury. When factor VIII is missing or not working properly, this process breaks down, and the blood cannot clot as it should. The result is that bleeding continues for much longer than it would in a person without the condition.

The condition is sometimes referred to as factor VIII deficiency because the core problem is the absence or shortage of this critical clotting factor. In healthy individuals, factor VIII acts as a powerful initiator of thrombin, which is a substance that generates fibrin—the material that forms the mesh-like structure of a blood clot. Without adequate factor VIII, the body produces less thrombin, and consequently, blood cannot clot properly. This leads to excessive bleeding that can occur either spontaneously or following injuries, surgical procedures, or dental work.

How Common Is This Condition?

Hemophilia A is the most common severe bleeding disorder linked to genetics. It occurs in approximately one out of every 5,000 males worldwide. This makes it significantly more prevalent than other forms of hemophilia, accounting for roughly 80% of all hemophilia cases. More than 400,000 males across the globe are estimated to live with hemophilia A, though many remain undiagnosed, particularly in developing countries where access to medical testing and care may be limited.

The condition affects males far more frequently than females due to how it is inherited. Because hemophilia A is passed down through families via a gene on the X chromosome, males are much more likely to develop symptoms. Females can carry the genetic change and may pass it to their children, but they usually do not experience severe symptoms themselves. However, approximately 30% of female carriers do have factor VIII levels below 40% of normal, which puts them at some risk for bleeding, especially after major trauma or surgical procedures. In rare cases, females can develop mild symptoms such as heavy menstrual periods.

The condition can appear in people of all ages. Two peaks in diagnosis are typically observed: one associated with pregnancy and childbirth, and another in older age, particularly in people over 60 years old. Approximately 1 to 5% of cases are diagnosed during pregnancy or within one year following childbirth.

What Causes Factor VIII Deficiency?

The vast majority of hemophilia A cases—about 70%—are caused by a genetic change that affects the F8 gene. This gene is responsible for providing instructions to the body on how to make factor VIII. When the gene contains a mutation or change, the body either cannot produce factor VIII at all, or it produces a version that does not work correctly. This genetic change is passed down through families in a specific pattern known as X-linked recessive inheritance.

The F8 gene sits on the X chromosome, one of the two chromosomes that determine biological sex. Females inherit two X chromosomes—one from each parent—while males inherit one X chromosome from their mother and one Y chromosome from their father. Because males have only one X chromosome, if that chromosome carries the altered F8 gene, they will develop hemophilia A. Males with hemophilia do not pass the condition to their sons, but all of their daughters will carry the genetic change.

Females who inherit one altered copy of the F8 gene are called carriers. They have a 50% chance of passing the genetic change to each of their children. Boys who receive the altered gene will have hemophilia A, while girls who receive it will become carriers themselves. Some female carriers may experience mild symptoms of hemophilia, particularly heavy menstrual bleeding.

In about 30% of cases, hemophilia A occurs without any family history of the condition. These cases result from a spontaneous genetic mutation that happens during the development of the egg or sperm, or early in the development of the embryo. When this happens, the person becomes the first in their family to have the condition, but they can then pass it on to their children.

There is also a rare form of the condition called acquired hemophilia A, which is not inherited. In acquired hemophilia A, the immune system produces proteins called autoantibodies that attack factor VIII. These autoantibodies prevent factor VIII from working properly. This form of the disease can occur in both men and women without any previous history of bleeding disorders. Approximately half of people with acquired hemophilia A have other medical conditions, most commonly autoimmune disorders or cancer. In some cases, acquired hemophilia A develops for no known reason.

Who Is at Risk?

Certain groups of people are more likely to develop factor VIII deficiency than others. The most significant risk factor is having a family history of bleeding disorders. Males whose mothers are carriers of the hemophilia gene have a 50% chance of inheriting the condition. Even if a family does not have a known history of hemophilia, spontaneous genetic mutations can occur, meaning anyone could potentially develop the condition, though this is relatively rare.

Being male is itself a major risk factor for hemophilia A. Because of the way the condition is inherited through the X chromosome, males are far more likely to develop symptoms than females. Males have only one X chromosome, so a single altered copy of the F8 gene is enough to cause the disease. Females would need altered copies on both of their X chromosomes to have severe hemophilia, which is extremely rare.

For acquired hemophilia A, different risk factors apply. This form of the condition is more common in older adults, particularly those over the age of 65. People with autoimmune diseases, cancer, or pregnancy-related complications are also at higher risk. Some medications and medical conditions can trigger the immune system to produce antibodies against factor VIII, though in many cases, the cause remains unknown.

Recognizing the Symptoms

The symptoms of factor VIII deficiency vary greatly depending on how much factor VIII a person has in their blood. People with severe hemophilia A typically have less than 1% of normal factor VIII levels, those with moderate hemophilia have 1% to 5% of normal levels, and those with mild hemophilia have 5% to 40% of normal levels. The lower the factor VIII level, the more severe and frequent the bleeding episodes tend to be.

People with severe hemophilia A often experience spontaneous bleeding—bleeding that occurs without any obvious injury or trauma. This can happen as often as two to five times per month if the person is not receiving preventive treatment. Spontaneous bleeding commonly occurs in the joints, particularly the knees, elbows, and ankles. When blood leaks into a joint space, it causes swelling, pain, stiffness, and a feeling of warmth in the affected joint. Over time, repeated bleeding into the same joint can lead to permanent damage, chronic pain, and limited mobility.

Bleeding can also occur in the muscles, creating deep, painful bruises called hematomas. These are different from the small, surface bruises that most people get from minor bumps. Hematomas in hemophilia can be large and can put pressure on nerves and blood vessels, potentially causing serious complications. Some people notice that they bruise very easily from everyday activities like bumping into furniture or playing sports.

Prolonged bleeding after cuts, tooth extractions, or surgery is a hallmark symptom of hemophilia A at all severity levels. A person might bleed much longer than expected from a small cut, or bleeding might stop temporarily and then start again hours or even days later. Dental procedures can be particularly problematic, as the mouth is a difficult area to bandage, and normal activities like eating and speaking can disrupt clots.

Nosebleeds that are difficult or impossible to stop are another common symptom. People with hemophilia A may also notice blood in their urine or stool, indicating internal bleeding in the urinary tract or digestive system. In severe cases, bleeding can occur in the brain, which is a life-threatening emergency requiring immediate medical attention. Signs of bleeding in the brain include severe headaches, repeated vomiting, unusual sleepiness, double vision, sudden weakness, or difficulty walking.

People with mild hemophilia A may not have any symptoms until they undergo surgery, have a tooth pulled, or experience significant trauma. Some people with mild hemophilia are not diagnosed until adulthood because their factor VIII levels are high enough to prevent spontaneous bleeding, but not high enough to prevent excessive bleeding after major injuries or procedures.

In infants and young children, the condition often becomes apparent when the child begins to crawl or walk and experiences bumps and falls. Sometimes hemophilia A is first noticed when a male infant is circumcised and experiences prolonged bleeding. In children, bleeding into joints may cause them to refuse to use an arm or leg, or they may limp or avoid physical activities.

Preventing Bleeding Episodes

While factor VIII deficiency cannot be prevented if it is inherited, there are many steps people with the condition can take to reduce their risk of bleeding episodes and complications. Prevention is a crucial part of managing hemophilia A, and many strategies focus on both medical treatment and lifestyle adjustments.

One of the most important preventive measures is prophylactic treatment, which means receiving regular infusions of factor VIII to keep blood levels high enough to prevent spontaneous bleeding. Many people with severe hemophilia begin prophylactic treatment in early childhood and continue it through adolescence and sometimes into adulthood. This approach has been shown to significantly reduce the number of bleeding episodes, prevent joint damage, and improve quality of life. The treatment involves injecting factor VIII concentrate into a vein, usually two to three times per week or as directed by a healthcare provider.

Regular medical care through a hemophilia treatment center is essential for prevention. These specialized centers have teams of healthcare providers who understand bleeding disorders and can provide comprehensive care, including regular check-ups, treatment planning, physical therapy, and education. Research has shown that people who receive care at hemophilia treatment centers have better health outcomes and are less likely to experience serious complications.

Physical activity and exercise are important for maintaining muscle strength and joint health, which can help protect against bleeding. However, people with hemophilia need to choose activities carefully. Low-impact activities like swimming, walking, cycling, and yoga are generally safe and beneficial. Contact sports and high-impact activities that carry a high risk of injury should be avoided or approached with extreme caution and proper protective equipment.

Avoiding certain medications is also crucial for prevention. Aspirin and non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen can interfere with blood clotting and should generally be avoided unless specifically recommended by a healthcare provider who knows about the hemophilia diagnosis. Some dietary supplements, including vitamin E, fish oil, ginkgo biloba, garlic, and ginger, may also increase bleeding risk and should be discussed with a doctor before use.

Maintaining a healthy weight is important because excess weight puts extra strain on joints, which can increase the risk of joint bleeding. A balanced diet that includes iron-rich foods can help replace iron lost through bleeding episodes. Good dental hygiene is essential to prevent gum disease and the need for dental procedures that could cause bleeding.

People with hemophilia should receive the hepatitis B vaccine, as they are at higher risk for hepatitis B due to potential exposure to blood products. Having an emergency kit ready with necessary supplies and medications can help ensure quick treatment if bleeding does occur.

How the Body Normally Stops Bleeding

To understand why factor VIII deficiency causes problems, it helps to know how blood normally clots. When a blood vessel is injured—such as when you cut your finger—the body immediately begins a complex process called hemostasis to stop the bleeding. This process involves many steps and requires numerous proteins, including factor VIII, to work together in a specific sequence.

The first response to an injury is that tiny cell fragments in the blood called platelets rush to the site of the wound. These platelets stick to the edges of the torn blood vessel and to each other, forming a temporary plug. Another protein called von Willebrand factor helps the platelets stick together. This is called primary hemostasis, and it provides immediate, but unstable, coverage of the wound.

To make the clot stronger and more stable, the body activates a series of reactions called the clotting cascade. This is where factor VIII plays its critical role. Factor VIII becomes activated and then works together with another clotting factor called factor IX. Together, they activate factor X, which is another protein in the cascade. This chain reaction leads to the production of thrombin, which is essential for creating fibrin.

Fibrin is a thread-like protein that weaves through and around the platelet plug, forming a mesh that holds everything together firmly. This fibrin mesh is what makes the clot stable enough to withstand the pressure of blood flow while the blood vessel underneath heals. Without enough factor VIII, this entire cascade is disrupted. The body cannot generate enough thrombin, which means it cannot produce adequate fibrin. The result is that only weak, unstable clots form, and bleeding continues.

In people with factor VIII deficiency, the primary hemostasis—the initial platelet plug—usually forms normally. This is why bleeding may not start immediately after an injury. However, because the clotting cascade cannot proceed properly, the clot remains weak and easily breaks down. This explains why bleeding in hemophilia is often prolonged or delayed, and why bleeding may stop temporarily only to start again hours later. The blood can form an initial plug, but cannot reinforce it with the strong fibrin mesh needed for lasting protection.

Factor VIII also needs protection from breaking down too quickly in the bloodstream. The von Willebrand factor serves this protective function by binding to factor VIII and shielding it from being destroyed by other proteins in the blood. When von Willebrand factor is also deficient or defective—a condition called von Willebrand disease—factor VIII breaks down more rapidly, leading to bleeding problems even if the body produces normal amounts of factor VIII.